DayJ.C.: Current population reports. Population projections of the United States by age, sex, race and Hispanic origin: 1995 to 2050. US Bureau of the Census.Washington, DC: US Government Printing Office; 1996: 5–1130. Available at: http://www.census.gov/prod/1/pop/p25-1130/p251130a.pdf
2.
La VecchiaC., LucchiniF., NegriE.: Cancer mortality in the elderly, 1960-1998: a worldwide approach.Oncol Spectr2001; 2: 386–394.
3.
YancikR., GanzP.A., VarricchioC.G.: Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base.J Clin Oncol2001; 19: 1147–1151.
4.
ExtermannM., OvercashJ., LymanG.H.: Comorbidity and functional status are independent in older cancer patients.J Clin Oncol1998; 16: 1582–1587.
5.
FriedL.P., WallaceR.B.: The complexity of chronic illness in the elderly: from clinic to community, in WallaceR.B., WoolsonR.E. (Eds): The epidemiologic study of the elderly, New York, Oxford University Press, Inc, 1992, pp 10–19.
6.
BalducciL., StantaG.: Cancer in the frail patient: a coming epidemic.Hematol Oncol Clin North Am2000, 14: 235–250.
7.
BalducciL., ExtermannM.: Cancer and aging: an evolving panorama.Hematol Oncol Clin North Am2000, 14: 1–16.
8.
MonfardiniS., FerrucciL., FratinoL.: Validation of a multidimensional evaluation scale for use in elderly cancer patients.Cancer1996; 77: 395–401.
Diaz-RubioE., BurrisH., DouillardJ.Y.: Safety of capecitabine compared to fluorouracil/leucovorin for the adjuvant treatment of elderly colon cancer patients.Proc ASCO2004; 23: abst 3737.
11.
ForbesL.M., SimmonsC., O'SheaT.: Frequency of axillary node dissection and chemotherapy in breast cancer patients over 60 years of age compared with those younger than 60 years of age.Proc ASCO2004; 23: abst 8161.
12.
ExquisB., AaproM., KohlerS.: Oxaliplatin in patients above age 70 suffering from metastatic colorectal cancer: an observational study.Proc ASCO2004; 23: abst 8042.
13.
ZauberN.P., ZauberA.G.: Hematologic data of healthy very old people.JAMA1987; 257: 2181–2184.
14.
AnjaB.J., SumanV.J., FairbanksV.F.: Prevalence of anemia in medical practice: community versus referral patients.Mayo Clin Proc1994; 69: 730–735.
15.
BlandL.B., TangenC.M., ThompsomI.M.: Prognostic value of anemia in untreated metastatic prostate cancer: a multivariate analysis of SWOG 8894.Proc ASCO2004; 23: abst 4574.
16.
BerardiR., TamburranoT., FianchiniA.: Perioperative anemia as prognostic factor in patients undergoing resection for non-small cell lung cancer.Proc ASCO2004; 23: abst 7179.
17.
BalducciL., CorcoranM.B.: Antineoplastic chemotherapy of the older cancer patient.Hematol Oncol Clin North Am2000, 14: 193–212.
18.
RizzoD., LichtinA.E., WoolfS.H.: Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).J Clin Oncol2002; 20: 4083–4107.
19.
RodgerL.Bick: Cancer-associated thrombosis.N Engl J Med July, 102003109–111.